Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

Por Duchmann, M, Braun, T, Micol, J-B, Platzbecker, U, Park, S, Pilorge, S, Beyne-Rauzy, O, Vey, N, Sébert, M, Gruson, B, Dumas, P-Y, Guieze, R, Chretien, M-L, Laribi, K, Chait, Y, Legros, L, Sahnes, L, Hirsch, P, Salanoubat, C, Solary, E, Fenaux, P, Itzykson, R
Publicado no Blood Cancer J (2017)